Provider review, September 2026

Lifeforce Review

Lifeforce publishes an eligible-state list on each product page, and the lists are not the same for the two compounds compared here. It bills the medication every twenty-five days, sells it only to members, and requires a paid diagnostic before the first order, so no single figure on the page is the cost of starting.

What Lifeforce charges

Lifeforce is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit Lifeforce

By Nora Castellan, Standards Editor

Twenty-five days is not a month

The purchase option on both product pages is labelled with a number of days rather than a month, and the page repeats the interval in a shipping line beneath it. That is a period that is neither weekly nor monthly and does not line up with a calendar.

This site records the figure with its own term and does no conversion. Dividing a per-25-day charge into a per-month one is arithmetic the seller does not do on its own page, and doing it here would put a number on this site that no company published.

The practical consequence is a scheduling one as much as a pricing one. A shorter cycle comes round more often than a month does, so the number of charges in a year is not twelve.

It also means these figures cannot be set beside a monthly plan from another seller without first choosing a length of time to hold both against.

Three charges on three different clocks

The same block appears on both product pages: pharmaceutical products are available only to members, membership is billed monthly, and qualifying requires residing in an eligible state and purchasing a diagnostic.

So there are three separate charges before a first delivery arrives — a one-time diagnostic, a recurring membership, and the medication itself on its own twenty-five-day cycle. The page states all three and never adds them together.

Any reading of the medication figure as the cost of access is wrong, and this row's qualifiers say so on both compounds rather than leaving it to the reader.

Two of the fifty-three sellers here describe lab work as included in the price. This is not one of them: blood testing is required and is sold as its own charge, which is the opposite arrangement.

Two eligible-state lists, four states apart

Each product page publishes a positive list of eligible states under its own heading. The sermorelin list runs to forty-eight states plus the District of Columbia; the PT-141 list is the same list minus four states.

The difference was computed as a set difference rather than eyeballed, and it runs one way only: every state eligible for PT-141 is eligible for sermorelin, and four states eligible for sermorelin are not eligible for PT-141.

This roster stores one state list per seller. The field holds the shorter of the two, so nothing is claimed here that is not true for both compounds, and the four-state gap is recorded in the row and named here.

Twenty-four of the fifty-three sellers compared here publish a state footprint of any kind, and this is one of the few that publishes more than one. Fourteen of the fifty-three carry PT-141 at all.

Named entities, and a catalogue that shows no prices

The terms name the operating company, its address and the state whose law governs, and the footer separately names each clinical practice entity by the state it operates in, alongside a statement that the operating company does not itself provide clinical services.

That is a fuller answer to who is charging you and who is treating you than most sellers here give, and the two roles are named separately rather than blurred.

The pharmaceutical catalogue is labelled members only in the site's own shop filter, and its category cards show no price at all. The figures exist only on each individual product page.

A reader who stops at the catalogue would conclude this seller publishes nothing. Eleven of the fifty-three sellers here name the facility that fills an order; this is one of the forty-two that do not.

Who it's for

  • Readers who will check an eligible-state list for their own compound rather than for the seller.
  • Buyers who want the clinical entity and the operating company named separately.
  • Shoppers willing to pay a diagnostic and a membership on top of the medication.
  • Anyone who wants the shipping interval stated in days rather than implied.

Who should look elsewhere

  • Buyers comparing monthly rates, because this seller's cycle is neither weekly nor monthly.
  • Readers who want one figure that covers the cost of starting, since three separate charges apply.
  • Anyone in one of the four states eligible for one of these compounds and not the other.
  • Shoppers who want lab work inside the price rather than sold as a required extra.
  • Buyers looking for GHK-Cu, glutathione or tesamorelin, none of which is on these product pages.

Strengths

  • Publishes a positive eligible-state list on each product page rather than a coverage sentence, and the two lists are different, which most sellers here never disclose
  • Names the operating company, its address and California as the governing law, and separately names each clinical practice entity by state
  • States the membership fee, the diagnostic fee and the medication charge as three distinct figures rather than one blended number
  • Prints the shipping interval in days on the purchase option itself, so the period is not left to inference

Trade-offs

  • Bills every 25 days, which is neither weekly nor monthly, so the figure cannot be set beside a monthly price without converting it
  • The medication figure is not the cost of access: a $599 diagnostic and a $149 monthly membership come first, and the page never adds the three together
  • Its eligible-state list for PT-141 is four states shorter than its list for sermorelin, so coverage has to be checked per compound
  • The pharmaceutical catalogue is labelled members only and its category pages show no price at all, so a shopper who stops at the catalogue sees nothing
  • No compounding pharmacy is named

How we verified this

A provider to compare Lifeforce against

Auren Rx

Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.

Read the full Auren Rx review

Auren Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit Auren Rx

Frequently asked questions

Is the published price monthly?

No. The purchase option is labelled in days, and the page says shipments go out on that interval. It is neither a week nor a month, and this site does not convert it into one.

Is the medication figure the cost of starting?

No. The same page says the product is sold only to members, that membership is billed monthly, and that qualifying requires buying a diagnostic first. Three separate charges apply and the page never adds them up.

Are the eligible states the same for both compounds?

No. The sermorelin list is four states longer than the PT-141 list, and every state on the PT-141 list also appears on the sermorelin one. Check the list on the page for the compound you want, not the seller's general coverage.

Why does the state count here look lower than the seller's own list?

Because this roster stores one list per seller and the field holds the shorter of the two published lists. That way nothing is claimed here that is not true for both compounds, and the difference is recorded rather than averaged.

Is lab work included?

No. Blood testing is required before a prescription and is sold as its own one-time charge, which is the opposite of a plan that folds labs into the price.

Why does the catalogue show no prices?

The pharmaceutical collection is labelled members only in the site's own filter and its cards carry no figures. The prices appear only on the individual product pages.

Lifeforce is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit Lifeforce